Literature DB >> 1237295

The reaction of penicillin with proteins.

P H Corran, S G Waley.   

Abstract

The mode of reaction of benzylpenicillin with two proteins was studied, with particular reference to the allergenicity of penicillin. These reactions, with pig insulin, and with hen's-egg-white lysozyme, were carried out in neutral solution at 37 degrees C. High concentrations of penicillin are needed to label the proteins, owing to concurrent hydrolysis of penicillin. Evidence has been obtained that the penicillin-reactive sites on the insulin molecule are the alpha-amino group at the N-terminus of the A chain and the epsilon-amino group of the lysine residue; whereas a site of reaction with lysozyme appears to be the epsilon-amino group of lysine-116.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1237295      PMCID: PMC1165629          DOI: 10.1042/bj1490357

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  The mechanism of inactivation of penicillin by cysteine and other mercaptoamines.

Authors:  K F NAKKEN; L ELDJARN; A PIHL
Journal:  Biochem Pharmacol       Date:  1960-05       Impact factor: 5.858

Review 2.  Allergy to penicillin and related antibiotics: antigenic and immunochemical mechanism.

Authors:  G T Stewart
Journal:  Annu Rev Pharmacol       Date:  1973       Impact factor: 13.820

3.  An interaction between lysozyme and penicillin.

Authors:  L N Johnson
Journal:  Proc R Soc Lond B Biol Sci       Date:  1967-04-18

4.  Amino acd sequence of chicken liver glutamate dehydrogenase.

Authors:  K Moon; D Piszkiewicz; E L Smith
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

5.  Environment and exposure to solvent of protein atoms. Lysozyme and insulin.

Authors:  A Shrake; J A Rupley
Journal:  J Mol Biol       Date:  1973-09-15       Impact factor: 5.469

6.  [Preparation and properties of acetyl derivatives of beef insulin. I].

Authors:  D Brandenburg; H G Gattner; A Wollmer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1972-04

7.  Amino acid sequences around the cysteine residues of rabbit muscle triose phosphate isomerase.

Authors:  J C Miller; S G Waley
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

8.  The reaction of 2,4,6-trinitrobenzenesulphonic acid with amino acids, Peptides and proteins.

Authors:  R B Freedman; G K Radda
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

9.  The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy.

Authors:  A L de Weck; C H Schneider; J Gutersohn
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

10.  The nature of amino acid side chains which are critical for the activity of lysozyme.

Authors:  S M Parsons; L Jao; F W Dahlquist; C L Borders; J Racs; T Groff; M A Raftery
Journal:  Biochemistry       Date:  1969-02       Impact factor: 3.162

View more
  4 in total

1.  Substrate-induced deactivation of penicillinases. Studies of beta-lactamase I by hydrogen exchange.

Authors:  P A Kiener; S G Waley
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

2.  Difference between type I autoimmune inhibitors of fibrin stabilization in two patients with severe hemorrhagic disorder.

Authors:  S Lopaciuk; K Bykowska; J M McDonagh; R P McDonagh; W J Yount; C R Fuller; L Cooperstein; A Gray; L Lorand
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  The exocellular beta-lactamase of Streptomyces albus G. Purification, properties and comparison with the exocellular DD-carboxypeptidase.

Authors:  C Duez; J M Frère; D Klein; M Noël; J M Ghuysen; L Delcambe; L Dierickx
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

4.  Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system.

Authors:  L Lorand; P T Velasco; J R Rinne; M Amare; L K Miller; M L Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.